Practical Neurology · 2019 · 22 citations · 8 references
A 22-year-old African woman developed acute behavioural change, against a background of sickle cell disease with strokes requiring a ventriculoperitoneal shunt. She alternated between mutism with prolonged staring and posturing, and a state of agitation with elation and echolalia. Cerebrospinal fluid (CSF) protein was elevated and electroencephalogram showed mild slowing with bitemporal slow and sharp waves. We suspected catatonia secondary to possible autoimmune encephalitis but her condition persisted despite intravenous methylprednisolone. After identifying a positive serum anti-gamma-aminobutyric acid-A (GABA<sub>A</sub>) antibody, treatment with intravenous immunoglobulin, oral corticosteroids and rituximab led to gradual improvement. Patients with catatonia may show reduced GABA<sub>A</sub> receptor density and there are two other reports of catatonia with anti-GABA<sub>A</sub> antibodies. This patient's treatment response supports the antibody's causative role.
8
Catatonia. I. Rating scale and standardized examination
G. Bush, Max Fink, Georgios Petrides et al. · Acta Psychiatrica Scandinavica · 1996 · 1K citations
Mar Petit‐Pedrol, Thaís Armangué, Xiaoyu Peng et al. · The Lancet Neurology · 2014 · 606 citations · Full text
Investigations in GABA <sub>A</sub> receptor antibody-associated encephalitis
Marianna Spatola, Mar Petit‐Pedrol, Mateus Mistieri Simabukuro et al. · Neurology · 2017 · 316 citations · Full text
Antibodies to GABA <sub>A</sub> receptor α1 and γ2 subunits
Philippa Pettingill, Holger Kramer, Jan Coebergh et al. · Neurology · 2015 · 180 citations · Full text